Differential effects of bariatric surgery versus exercise on excessive visceral fat deposits

Medicine (United States)

Volumn 95, Issue 5, 2016, Pages

  Wu, Fu Zong ^a,b   Huang, Yi Luan ^a,b   Wu, Carol C ^c   Wang, Yen Chi ^a   Pan, Hsiang Ju ^a   Huang, Chin Kun ^d   Yeh, Lee Ren ^d   Wu, Ming Ting ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EPICARDIAL ADIPOSE TISSUE; EXERCISE; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; OBESITY; PARACARDIAL ADIPOSE TISSUE; PRIORITY JOURNAL; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; KINESIOTHERAPY; MIDDLE AGED; OBESITY, MORBID; PATHOLOGY; PERICARDIUM; STATISTICS AND NUMERICAL DATA;

ADIPOSITY; ADULT; BARIATRIC SURGERY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; EXERCISE THERAPY; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, MORBID; PERICARDIUM; SUBCUTANEOUS FAT, ABDOMINAL; WEIGHT LOSS;

EID: 84958817382     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002616     Document Type: Article

References (45)

1. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:214.
2. Despres J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-887.
3. Després J-P, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039-1049.
4. Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes. 2008;32:619-628.
5. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907-917.
6. Ngo DT, Gokce N. Epicardial adipose tissue: a benign consequence of obesity? Circ Cardiovasc Imaging. 2015;8:e003156.
7. Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43:1651-1654.
8. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605-613.
9. Djaberi R, Schuijf JD, van Werkhoven JM, et al. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol. 2008;102:1602-1607.
10. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1-7.
11. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460-2466.
12. Kankaanpaä M, Lehto H-R, Pärkkä JP, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metabol. 2006;91:4689-4695.
13. de Roos A. Reversibility of intrathoracic lipotoxicity in obesity after bariatric surgeryuse of magnetic resonance imaging. J Am Coll Cardiol. 2012;60:1390-1392.
14. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837-e841.
15. Borel A-L, Nazare J-A, Smith J, et al. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity. 2012;20:1223-1233.
16. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus nonsurgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
17. Gaborit B, Jacquier A, Kober F, et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60:1381-1389.
18. van Schinkel LD, Sleddering MA, Lips MA, et al. Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function. Clin Endocrinol. 2014;81:689-695.
19. Foppa M, Pond KK, Jones DB, et al. Subcutaneous fat thickness, but not epicardial fat thickness, parallels weight reduction three months after bariatric surgery: a cardiac magnetic resonance study. Int J Cardiol. 2013;168:4532-4533.
20. Nakazato R, Rajani R, Cheng VY, et al. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis. 2012;220:139-144.
21. Willens HJ, Byers P, Chirinos JA, et al. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol. 2007;99:1242-1245.
22. Kokkinos A, Alexiadou K, Liaskos C, et al. Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg. 2013;23:31-38.
23. Fu C-P, Sheu WHH, Lee IT, et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clinica Chimica Acta. 2013;421:98-103.
24. Jonker JT, de Mol P, de Vries ST, et al. Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function. Radiology. 2013;269:434-442.
25. Chaowalit N, Somers VK, Pellikka PA, et al. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis. 2006;186:354-359.
26. Gorter PM, van Lindert ASR, de Vos AM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis. 2008;197:896-903.
27. Saura D, Oliva MJ, Rodr?guez D, et al. Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol. 2010;141:311-313.
28. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The Evidence Report. National Institutes of Health. Obesity Res. 1998;6 (suppl 2):51S-209S.
29. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283-286.
30. Wu F-Z, Huang Y-L, Wang Y-C, et al. Impact of location of epicardial adipose tissue, measured by coronary artery calciumscoring computed tomography on obstructive coronary artery disease. Am J Cardiol. 2013;112:943-949.
31. Snel M, Jonker JT, Hammer S, et al. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients. Obesity. 2012;20:1572-1576.
32. Schneiter SM. Effects of weight loss on pericardial fat and left ventricular mass assessed with cardiac magnetic resonance imaging in morbid obesity. Int J Clin Med. 2011;02:360-366.
33. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311-1319.
34. Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab. 2011;22:450-457.
35. Halberg N, Khan T, Trujillo ME, et al. Hypoxia-Inducible Factor 1 (Induces Fibrosis and Insulin Resistance in White Adipose Tissue. Mol Cell Biol. 2009;29:4467-4483.
36. Divoux A, Tordjman J, Lacasa D, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59:2817-2825.
37. Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes. 2007;32:268-274.
38. Ionut V, Burch M, Youdim A, et al. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity. 2013;21:1093-1103.
39. Finelli C, Tarantino G. Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? World J Gastroenterol. 2012;18:6790-6800.
40. Keating SE, Hackett DA, Parker HM, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63:174-182.
41. Kritchevsky SB, Beavers KM, Miller ME, et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One. 2015;10:e0121993.
42. Bastien M, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369-381.
43. Pack QR, Rodriguez-Escudero JP, Thomas RJ, et al. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89:1368-1377.
44. Swift DL, Johannsen NM, Lavie CJ, et al. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis. 2014;56:441-447.
45. Ades PA, Savage PD. Potential benefits of weight loss in coronary heart disease. Prog Cardiovasc Dis. 2014;56:448-456.